Due to the relatively small sample size, further studies are necessary to confirm the excellent predictive capacity of Cystatin C and to investigate whether preventive interventions based on this biomarker can help to reduce postoperative AKI as well as associated morbidity and mortality. Here, CST3 is linked to acute kidney injury.